HIV Treatment Live Virtual Event

Causes of Viremia and Strategies to Support Viral Suppression

Catherine Creticos, MD, Tuesday, October 28, 2025, 12:00 pm - 1:00 pm CT

Review the clinical definitions associated with viremia development and learn about approaches in care and clinical considerations in treatment-experienced people with HIV. This program outlines guidelines-based considerations for providers when individuals are experiencing virologic failure, strategies to support adherence and continued engagement in care, and factors to consider when restarting ART to achieve and maintain virologic suppression.

These non-CME educational programs and speakers are sponsored by Gilead Sciences, Inc.

Please register to sign up for this event.

*Required field

First name*

Last name*

Email address* Confirm email address*

Professional designation*

Business address*

Suite/room/dept

City*

State*

ZIP/postal code*

Business phone

Mobile phone

The information you provide will be subject to Gilead’s Privacy Statement.

I certify that I am a US healthcare professional.*

Text Reminder Opt-In

I consent to receive reminder communications from Gilead and its service providers to my mobile number provided, including text messages. Text and data rates may apply. I understand that I may opt out at any time by texting “STOP.”

Communication Consent

I agree and consent to receive emails and phone calls related to the administration of this webinar at the email address and phone number I have provided, including cell phone numbers if provided. Data rates may apply.*

I want to stay informed on related future webinars, events, and other informational materials by receiving communication via emails and text messages at the email address and phone number I have provided. Text and data rates may apply. I understand that I may opt out at any time by texting “STOP.”

HIV Virtual Event Registration | HIV Clinical Insights

HIV Treatment Live Virtual Event

Please register to sign up for this event.

The information you provide will be subject to Gilead’s Privacy Statement.

Text Reminder Opt-In

Communication Consent